Table 2.
Lapatinib + nab-paclitaxel (n = 60) | |
---|---|
Number of organs involved, n (%) | |
1 | 12 (20) |
2 | 25 (42) |
≥3 | 23 (38) |
Sites of disease, n (%) | |
Lymph nodes | 38 (63) |
Lung | 32 (53) |
Liver | 24 (40) |
Bone | 16 (27) |
Breast (de novo Stage IV) | 12 (20) |
Lapatinib + nab-paclitaxel (n = 60) | |
---|---|
Number of organs involved, n (%) | |
1 | 12 (20) |
2 | 25 (42) |
≥3 | 23 (38) |
Sites of disease, n (%) | |
Lymph nodes | 38 (63) |
Lung | 32 (53) |
Liver | 24 (40) |
Bone | 16 (27) |
Breast (de novo Stage IV) | 12 (20) |